secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001839882-23-026088
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals prices $4.5M public offering of common stock and warrants
-------------------------------------------------------------------------------

- Offering comprises 9M shares, 9M Series A warrants (5-yr, $0.50 exercise), 9M Series B warrants (1-yr, $0.50); combined price $0.50 per unit.
- Gross proceeds ~$4.5M; net proceeds for working capital, manufacturing & R&D facilities, and product acquisition/licensing.
- Placement agents A.G.P./Alliance Global Partners and Brookline Capital Markets; 7.0% cash fee plus up to $100k expense reimbursement.
- Closing expected on or about October 3, 2023, subject to customary closing conditions.
- Directors and officers subject to 60-day lock-up on sale of securities post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/tnxp-8k_092823.htm
  HTML page:      https://secwatch.observer/filing/0001839882-23-026088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer